Skip to main content
Midas Edge

Sabra Health Care REIT, Inc.

For the period ended Sep 30, 2026. Filed Nov 2, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 2, 2026

SBRA$21.47+2.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Equity

Common Stock · Additional Paid-in Capital · Cumulative Distributions in Excess of Net Income · Accumulated Other Comprehensive Loss · Total Stockholders’Equity · Noncontrolling Interests · Total Equity
Shares · Amounts
Balance, June 30, 2025239,792,173$2,398$4,625,050$(1,913,932)$(2,031)$2,711,485$—$2,711,485
Net income (loss)———22,538—22,538(21)22,517
Other comprehensive loss————(3,945)(3,945)—(3,945)
Contributions from noncontrolling interests——————2,0402,040
Amortization of stock-based compensation——3,879——3,879—3,879
Common stock issuance, net9,557,50095163,824——163,919—163,919
Common dividends ($0.30 per share)———(72,942)—(72,942)—(72,942)
Balance, September 30, 2025249,349,673$2,493$4,792,753$(1,964,336)$(5,976)$2,824,934$2,019$2,826,953
Common Stock · Additional Paid-in Capital · Cumulative Distributions in Excess of Net Income · Accumulated Other Comprehensive Income · Total Stockholders’Equity · Noncontrolling Interests · Total Equity
Shares · Amounts
Balance, June 30, 2026255,462,756$2,555$4,893,653$(2,151,582)$6,097$2,750,723$1,717$2,752,440
Net income (loss)———28,607—28,607(50)28,557
Other comprehensive income————16,98616,986—16,986
Distributions to noncontrolling interests——————(43)(43)
Amortization of stock-based compensation——4,980——4,980—4,980
Common stock issuance, net6,498,70565115,986——116,051—116,051
Common dividends ($0.30 per share)———(77,696)—(77,696)—(77,696)
Balance, September 30, 2026261,961,461$2,620$5,014,619$(2,200,671)$23,083$2,839,651$1,624$2,841,275

CONSOLIDATED STATEMENTS OF EQUITY (CONTINUED)

Common Stock · Additional Paid-in Capital · Cumulative Distributions in Excess of Net Income · Accumulated Other Comprehensive Income (Loss) · Total Stockholders’Equity · Noncontrolling Interests · Total Equity
Shares · Amounts
Balance, December 31, 2024237,586,882$2,376$4,592,605$(1,874,633)$20,940$2,741,288$—$2,741,288
Net income (loss)———128,384—128,384(21)128,363
Other comprehensive loss————(26,916)(26,916)—(26,916)
Contributions from noncontrolling interests——————2,0402,040
Amortization of stock-based compensation——11,685——11,685—11,685
Common stock issuance, net11,762,791117188,463——188,580—188,580
Common dividends ($0.90 per share)———(218,087)—(218,087)—(218,087)
Balance, September 30, 2025249,349,673$2,493$4,792,753$(1,964,336)$(5,976)$2,824,934$2,019$2,826,953
Common Stock · Additional Paid-in Capital · Cumulative Distributions in Excess of Net Income · Accumulated Other Comprehensive (Loss) Income · Total Stockholders’Equity · Noncontrolling Interests · Total Equity
Shares · Amounts
Balance, December 31, 2025251,697,456$2,517$4,836,270$(2,013,375)$(3,571)$2,821,841$1,947$2,823,788
Net income (loss)———44,285—44,285(163)44,122
Other comprehensive income————26,65426,654—26,654
Contributions from noncontrolling interests——————22
Distributions to noncontrolling interests——————(162)(162)
Amortization of stock-based compensation——14,738——14,738—14,738
Common stock issuance, net10,264,005103163,611——163,714—163,714
Common dividends ($0.90 per share)———(231,581)—(231,581)—(231,581)
Balance, September 30, 2026261,961,461$2,620$5,014,619$(2,200,671)$23,083$2,839,651$1,624$2,841,275
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.